Ingalls & Snyder LLC Purchases 667 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Ingalls & Snyder LLC grew its position in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 8.5% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 8,527 shares of the healthcare conglomerate’s stock after buying an additional 667 shares during the period. Ingalls & Snyder LLC’s holdings in UnitedHealth Group were worth $4,986,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also modified their holdings of the company. Apella Capital LLC grew its position in UnitedHealth Group by 37.3% during the second quarter. Apella Capital LLC now owns 1,120 shares of the healthcare conglomerate’s stock worth $551,000 after buying an additional 304 shares in the last quarter. Thomasville National Bank lifted its position in UnitedHealth Group by 3.3% during the second quarter. Thomasville National Bank now owns 1,318 shares of the healthcare conglomerate’s stock worth $671,000 after purchasing an additional 42 shares during the period. Cullinan Associates Inc. increased its holdings in UnitedHealth Group by 25.8% in the 2nd quarter. Cullinan Associates Inc. now owns 20,952 shares of the healthcare conglomerate’s stock valued at $10,670,000 after buying an additional 4,298 shares during the period. Matrix Trust Co lifted its holdings in shares of UnitedHealth Group by 5.7% during the 2nd quarter. Matrix Trust Co now owns 3,352 shares of the healthcare conglomerate’s stock worth $1,707,000 after acquiring an additional 181 shares during the period. Finally, RDA Financial Network increased its stake in UnitedHealth Group by 4.3% in the second quarter. RDA Financial Network now owns 8,866 shares of the healthcare conglomerate’s stock valued at $4,515,000 after acquiring an additional 363 shares during the last quarter. 87.86% of the stock is currently owned by institutional investors and hedge funds.

UnitedHealth Group Trading Up 0.2 %

Shares of UNH stock traded up $1.18 during mid-day trading on Tuesday, hitting $609.70. The company’s stock had a trading volume of 345,690 shares, compared to its average volume of 3,839,901. The company has a market cap of $561.09 billion, a PE ratio of 39.64, a P/E/G ratio of 1.79 and a beta of 0.58. The company’s fifty day simple moving average is $585.43 and its 200-day simple moving average is $556.65. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.91 and a current ratio of 0.91. UnitedHealth Group Incorporated has a 52 week low of $436.38 and a 52 week high of $630.73.

UnitedHealth Group (NYSE:UNH) last released its quarterly earnings data on Tuesday, October 15th. The healthcare conglomerate reported $7.15 earnings per share for the quarter, beating the consensus estimate of $7.00 by $0.15. The company had revenue of $100.82 billion during the quarter, compared to analyst estimates of $99.14 billion. UnitedHealth Group had a net margin of 3.63% and a return on equity of 26.37%. UnitedHealth Group’s revenue for the quarter was up 9.2% compared to the same quarter last year. During the same quarter in the previous year, the business posted $6.56 EPS. As a group, equities research analysts expect that UnitedHealth Group Incorporated will post 27.6 earnings per share for the current fiscal year.

UnitedHealth Group Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Tuesday, December 17th. Shareholders of record on Monday, December 9th will be issued a $2.10 dividend. The ex-dividend date of this dividend is Monday, December 9th. This represents a $8.40 annualized dividend and a yield of 1.38%. UnitedHealth Group’s payout ratio is currently 54.72%.

Analyst Ratings Changes

Several brokerages have recently issued reports on UNH. Truist Financial reiterated a “buy” rating and issued a $625.00 price target (down previously from $640.00) on shares of UnitedHealth Group in a research note on Wednesday, October 16th. Hsbc Global Res cut shares of UnitedHealth Group from a “strong-buy” rating to a “hold” rating in a report on Thursday, October 17th. Morgan Stanley lowered their price objective on shares of UnitedHealth Group from $615.00 to $610.00 and set an “overweight” rating for the company in a research report on Wednesday, October 16th. TD Cowen boosted their target price on shares of UnitedHealth Group from $601.00 to $609.00 and gave the stock a “buy” rating in a research note on Friday, October 18th. Finally, Bank of America cut their price objective on UnitedHealth Group from $675.00 to $650.00 and set a “buy” rating on the stock in a report on Wednesday, October 16th. Four investment analysts have rated the stock with a hold rating, seventeen have given a buy rating and two have given a strong buy rating to the company’s stock. According to MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus target price of $621.58.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.